Your browser doesn't support javascript.
loading
[Thalidomide: mechanisms of action and new insights in hematology]. / Thalidomide: mécanismes d'action et indications en hématologie.
Leleu, X; Micol, J B; Guieze, R; Berthon, C; Kuhnovsky, F; Terriou, L; Moreau, A S; Yakoub-Agha, I; Bauters, F; Facon, T.
Affiliation
  • Leleu X; Service des maladies du sang, hôpital Claude-Huriez, CHRU, Lille, France.
Rev Med Interne ; 26(2): 119-27, 2005 Feb.
Article in Fr | MEDLINE | ID: mdl-15710258
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Angiogenesis Inhibitors / Hematologic Diseases / Multiple Myeloma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Fr Journal: Rev Med Interne Year: 2005 Document type: Article Affiliation country: Francia Country of publication: Francia
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Angiogenesis Inhibitors / Hematologic Diseases / Multiple Myeloma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: Fr Journal: Rev Med Interne Year: 2005 Document type: Article Affiliation country: Francia Country of publication: Francia